MedTrace Logo

Comparing the Use of Vitamin c (Ascorbic Acid) in Eye Burn in Subconjunctival Injection to Topical or Oral Treatment.

NCT00734695 · Status: WITHDRAWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2010-03-02

No results posted yet for this study

Summary

Eye burns may cause a severe permanent damage. One kind of treatment is the use of vitamin C (Ascorbic acid). This study will compare between subconjunctival topical and/or systemic route of administration and topical and/or systemic administration.

Conditions

  • Burn

Interventions

DIETARY_SUPPLEMENT

vitamin c

Subconjunctival daily or bid

DIETARY_SUPPLEMENT

vitamin c

topical and systemic

DIETARY_SUPPLEMENT

vitamin c

topical systemic

Sponsors & Collaborators

  • Rambam Health Care Campus

    collaborator OTHER

  • Soroka University Medical Center

    collaborator OTHER

  • The Baruch Padeh Medical Center, Poriya

    lead OTHER_GOV

Principal Investigators

  • naftali modi, MD · Baruch Pade medical center

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-07-31
Primary Completion
2009-11-30
Completion
2010-02-28

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00734695 on ClinicalTrials.gov